Aditxt is trading at $0.00, up +10.00%, with no clear company-specific catalyst identified on September 22, 2026.
- Available coverage continues to reference earlier Ignite Proteomics transaction and financing developments, rather than a fresh announcement.
- The broader market is mixed, with Nasdaq up only modestly; the move may reflect low-priced-stock volatility or positioning.
- No reliable evidence currently ties the gain directly to company news.